Literature DB >> 25326550

CMV and glioma--are we there yet?

Jason T Huse1, Kenneth Aldape1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25326550      PMCID： PMC4201080          DOI： 10.1093/neuonc/nou296

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

2.  Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study.

Authors:  D Oh; R A Prayson
Journal:  Arch Pathol Lab Med       Date:  1999-10       Impact factor: 5.534

3.  Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.

Authors:  Joseph D Khoury; Nizar M Tannir; Michelle D Williams; Yunxin Chen; Hui Yao; Jianping Zhang; Erika J Thompson; Funda Meric-Bernstam; L Jeffrey Medeiros; John N Weinstein; Xiaoping Su
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

4.  Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme.

Authors:  Ka-Wei Tang; Kristoffer Hellstrand; Erik Larsson
Journal:  Int J Cancer       Date:  2014-07-07       Impact factor: 7.396

5.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

6.  The landscape of viral expression and host gene fusion and adaptation in human cancer.

Authors:  Ka-Wei Tang; Babak Alaei-Mahabadi; Tore Samuelsson; Magnus Lindh; Erik Larsson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response.

Authors:  Érika Cosset; Tom J Petty; Valérie Dutoit; Samuel Cordey; Ismael Padioleau; Patricia Otten-Hernandez; Laurent Farinelli; Laurent Kaiser; Pascale Bruyère-Cerdan; Diderik Tirefort; Soraya Amar El-Dusouqui; Zeynab Nayernia; Karl-Heinz Krause; Evgeny M Zdobnov; Pierre-Yves Dietrich; Emmanuel Rigal; Olivier Preynat-Seauve
Journal:  Int J Cancer       Date:  2014-05-08       Impact factor: 7.396
  7 in total
  4 in total

1.  No circulating human cytomegalovirus in 14 cases of glioblastoma.

Authors:  Steven Lehrer; Sheryl Green; Kenneth E Rosenzweig; Angela Rendo
Journal:  Neuro Oncol       Date:  2014-12-01       Impact factor: 12.300

2.  Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors).

Authors:  Martin Michaelis; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2015-07       Impact factor: 12.300

Review 3.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

Review 4.  If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Tamara L Lotan; Ibrahim Kulac; Jessica L Hicks; Qizhi Zheng; Charles J Bieberich; Michael C Haffner; Angelo M De Marzo
Journal:  Asian J Urol       Date:  2018-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.